[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![raghavwadhwa Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::100281231.png) Raghav Wadhwa [@raghavwadhwa](/creator/twitter/raghavwadhwa) on x 97.1K followers
Created: 2025-07-17 09:09:28 UTC

🔷Patent Expiry and Market Dynamics: The Door Opens for Indian Generics:  
🔸A pivotal event shaping the GLP-1 market in India is the scheduled expiration of Novo Nordisk’s patent for semaglutide (marketed as Wegovy and Ozempic) in 2026. This patent cliff creates an opportunity for Indian pharmaceutical manufacturers to launch generic versions, which is likely to drive down prices and expand patient access.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945772831339340175/c:line.svg)

**Related Topics**
[ozempic](/topic/ozempic)
[wegovy](/topic/wegovy)
[novo](/topic/novo)
[india](/topic/india)

[Post Link](https://x.com/raghavwadhwa/status/1945772831339340175)